Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

UNC1062

UNC1062 is a highly selective tyrosine kinase (MERTK) inhibitor with an IC50 of 1.1 nM (Morrison Ki = 0.33 nM) . UNC1062 exhibits good selectivity for the TAM family (TYRO3 IC50 = 60 nM, AXL IC50 = 85 nM) . UNC1062 exhibits significant anti-proliferative effects and induces apoptosis in various cancer models (such as melanoma, gastric cancer, and acute myeloid leukemia) . UNC1062 inhibits multiple pathways, including MAPK/ERK, PI3K/AKT and JAK/STAT and affects the motility of head and neck squamous cell carcinoma (HNSCC) cells through the RhoA signaling pathway. UNC1062 inhibits macrophage efferocytosis, and it suitable for research on atherosclerosis[1][2][3][4][5].

Product Specifications

CAS Number

1350549-36-8

UNSPSC

12352005

Target

Akt; Apoptosis; ERK; JAK; p38 MAPK; PI3K; STAT; TAM Receptor

Type

Reference compound

Related Pathways

Apoptosis; Epigenetics; JAK/STAT Signaling; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/unc1062.html

Purity

98.92

Solubility

DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O[C@H]1CC[C@H](N2N=C(C3=CC=C(S(=O)(N4CCOCC4)=O)C=C3)C5=CN=C(NCCCC)N=C52)CC1

Molecular Formula

C25H34N6O4S

Molecular Weight

514.64

References & Citations

[1]Schlegel J, et al. MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest. 2013;123 (5) :2257-2267. |[2]Koda Y, Itoh M, Tohda S. Effects of MERTK Inhibitors UNC569 and UNC1062 on the Growth of Acute Myeloid Leukaemia Cells. Anticancer Res. 2018 Jan;38 (1) :199-204.|[3]Yi JH, et al. MerTK is a novel therapeutic target in gastric cancer. Oncotarget. 2015 Apr 20;8 (57) :96656-96667.|[4]von Mässenhausen A, et al. MERTK as a novel therapeutic target in head and neck cancer. Oncotarget. 2016 May 31;7 (22) :32678-94. |[5]Lu N, et al. Modulation of oxidized low-density lipoprotein-affected macrophage efferocytosis by mitochondrial calcium uniporter in a murine model. Immunol Lett. 2023 Nov;263:14-24.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

Akt; Axl; ERK1; ERK2; STAT6; Tyro3

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

3-Bromophenylacetic Acid
TRC-B686415-5G 5 g

3-Bromophenylacetic Acid

Sign In for Pricing
View Details
SHANK2 Recombinant Rabbit monoclonal Antibody
HA723226 100 µL

SHANK2 Recombinant Rabbit monoclonal Antibody

Sign In for Pricing
View Details
CD59 Mouse Monoclonal Antibody [Clone ID: p282 (H19)]
AM08350PU-N 50 µg

CD59 Mouse Monoclonal Antibody [Clone ID: p282 (H19)]

Sign In for Pricing
View Details
Myosin, Smooth Muscle Heavy Chain (MYH11/923 + SMMS-1), CF647 conjugate, 0.1mg/mL
BNC471136-100 1x 100 µL

Myosin, Smooth Muscle Heavy Chain (MYH11/923 + SMMS-1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
5,6-Diaminopyrimidine-2,4-diol-13C3 Hydrochloride
TRC-D416757-5MG 5 mg

5,6-Diaminopyrimidine-2,4-diol-13C3 Hydrochloride

Sign In for Pricing
View Details
5Alpha-Cholestan-3Alpha-ol-2,2,3,4,4-d5
TRC-C431743-5MG 5 mg

5Alpha-Cholestan-3Alpha-ol-2,2,3,4,4-d5

Sign In for Pricing
View Details